End-of-day quote
BURSA MALAYSIA
06:00:00 2024-06-05 pm EDT
|
5-day change
|
1st Jan Change
|
0.915
MYR
|
+2.23%
|
|
+2.81%
|
-2.66%
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,182
|
10,401
|
8,638
|
2,332
|
2,061
|
2,345
|
-
|
-
|
Enterprise Value (EV)
1 |
2,400
|
9,548
|
5,121
|
-467.4
|
18.07
|
2,345
|
2,345
|
2,345
|
P/E ratio
|
17.7
x
|
19.9
x
|
2.25
x
|
3.16
x
|
-14.1
x
|
-96.3
x
|
108
x
|
45.8
x
|
Yield
|
0.9%
|
-
|
9.64%
|
12.6%
|
4.38%
|
0.51%
|
0.82%
|
1.44%
|
Capitalization / Revenue
|
1.47
x
|
4.88
x
|
1.21
x
|
0.87
x
|
2.51
x
|
2.51
x
|
1.92
x
|
1.66
x
|
EV / Revenue
|
1.47
x
|
4.88
x
|
1.21
x
|
0.87
x
|
2.51
x
|
2.51
x
|
1.92
x
|
1.66
x
|
EV / EBITDA
|
9.46
x
|
13.6
x
|
1.71
x
|
2.03
x
|
-19.8
x
|
24.9
x
|
17.4
x
|
10.2
x
|
EV / FCF
|
19.4
x
|
9.41
x
|
2.71
x
|
-28
x
|
-2.92
x
|
-7.24
x
|
-47.4
x
|
-391
x
|
FCF Yield
|
5.16%
|
10.6%
|
36.9%
|
-3.58%
|
-34.2%
|
-13.8%
|
-2.11%
|
-0.26%
|
Price to Book
|
2.01
x
|
6.51
x
|
1.8
x
|
0.48
x
|
0.45
x
|
0.54
x
|
0.54
x
|
0.54
x
|
Nbr of stocks (in thousands)
|
2,612,995
|
2,600,243
|
2,617,639
|
2,664,861
|
2,576,120
|
2,562,620
|
-
|
-
|
Reference price
2 |
0.8350
|
4.000
|
3.300
|
0.8750
|
0.8000
|
0.9150
|
0.9150
|
0.9150
|
Announcement Date
|
8/30/19
|
8/10/20
|
8/26/21
|
8/22/22
|
8/29/23
|
-
|
-
|
-
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,489
|
2,132
|
7,164
|
2,687
|
821.9
|
934.5
|
1,223
|
1,414
|
EBITDA
1 |
230.6
|
763.6
|
5,061
|
1,150
|
-104
|
94
|
134.9
|
230.4
|
EBIT
1 |
186.9
|
687.5
|
4,993
|
1,087
|
-190.3
|
-12
|
21.02
|
103.4
|
Operating Margin
|
12.55%
|
32.25%
|
69.69%
|
40.47%
|
-23.15%
|
-1.28%
|
1.72%
|
7.32%
|
Earnings before Tax (EBT)
1 |
172.6
|
688.6
|
5,019
|
1,070
|
-196.7
|
-40.5
|
37.5
|
91
|
Net income
1 |
123.8
|
525.6
|
3,813
|
732.4
|
-149.4
|
-28.93
|
25.9
|
73.75
|
Net margin
|
8.31%
|
24.65%
|
53.22%
|
27.26%
|
-18.18%
|
-3.1%
|
2.12%
|
5.22%
|
EPS
2 |
0.0472
|
0.2011
|
1.469
|
0.2770
|
-0.0567
|
-0.009500
|
0.008500
|
0.0200
|
Free Cash Flow
1 |
112.5
|
1,105
|
3,185
|
-83.39
|
-705.6
|
-324
|
-49.5
|
-6
|
FCF margin
|
7.55%
|
51.83%
|
44.46%
|
-3.1%
|
-85.86%
|
-34.67%
|
-4.05%
|
-0.42%
|
FCF Conversion (EBITDA)
|
48.8%
|
144.68%
|
62.92%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
90.92%
|
210.21%
|
83.53%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.007500
|
-
|
0.3180
|
0.1100
|
0.0350
|
0.004670
|
0.007500
|
0.0132
|
Announcement Date
|
8/30/19
|
8/10/20
|
8/26/21
|
8/22/22
|
8/29/23
|
-
|
-
|
-
|
Fiscal Period: June |
2024 Q3
|
---|
Net sales
|
-
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
-0.686
|
Net margin
|
-
|
EPS
2 |
-0.000300
|
Dividend per Share
|
-
|
Announcement Date
|
5/28/24
|
Fiscal Period: June |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
218
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
853
|
3,517
|
2,799
|
2,043
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.946
x
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
113
|
1,105
|
3,185
|
-83.4
|
-706
|
-324
|
-49.5
|
-6
|
ROE (net income / shareholders' equity)
|
10.5%
|
38.8%
|
121%
|
15.3%
|
-3.17%
|
-0.53%
|
1.14%
|
1.85%
|
ROA (Net income/ Total Assets)
|
6.5%
|
20.6%
|
74%
|
11%
|
-2.69%
|
-0.6%
|
0.8%
|
1.1%
|
Assets
1 |
1,904
|
2,547
|
5,151
|
6,663
|
5,552
|
4,822
|
3,237
|
6,705
|
Book Value Per Share
2 |
0.4200
|
0.6100
|
1.830
|
1.820
|
1.770
|
1.700
|
1.680
|
1.700
|
Cash Flow per Share
|
-
|
-
|
1.390
|
0.1200
|
-
|
-
|
-
|
-
|
Capex
1 |
116
|
192
|
435
|
409
|
571
|
300
|
150
|
150
|
Capex / Sales
|
7.77%
|
9%
|
6.08%
|
15.22%
|
69.45%
|
32.1%
|
12.27%
|
10.61%
|
Announcement Date
|
8/30/19
|
8/10/20
|
8/26/21
|
8/22/22
|
8/29/23
|
-
|
-
|
-
|
Last Close Price
0.915
MYR Average target price
0.9583
MYR Spread / Average Target +4.74% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.66% | 499M | | +7.46% | 27.22B | | -40.47% | 2.63B | | -23.19% | 2.31B | | +18.15% | 2.32B | | +7.15% | 2.24B | | +17.78% | 1.81B | | -18.63% | 1.72B | | +25.92% | 1.33B | | -2.40% | 1.25B |
Medical Supplies
|